CROMOLYN SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cromolyn Sodium, and when can generic versions of Cromolyn Sodium launch?
Cromolyn Sodium is a drug marketed by Ailex Pharms Llc, Genera Pharms, Micro Labs Ltd India, Rising, Apotex Inc, Sandoz, Sciegen Pharms Inc, Actavis Mid Atlantic, Bausch, Eugia Pharma, Hikma, Micro Labs, Roxane, Teva Pharms, Virtus, Watson Labs, Wockhardt Bio Ag, Bausch And Lomb, Hh And P, and Perrigo. and is included in twenty-two NDAs.
The generic ingredient in CROMOLYN SODIUM is cromolyn sodium. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cromolyn Sodium
A generic version of CROMOLYN SODIUM was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CROMOLYN SODIUM?
- What are the global sales for CROMOLYN SODIUM?
- What is Average Wholesale Price for CROMOLYN SODIUM?
Summary for CROMOLYN SODIUM
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 22 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 23 |
| Patent Applications: | 4,783 |
| What excipients (inactive ingredients) are in CROMOLYN SODIUM? | CROMOLYN SODIUM excipients list |
| DailyMed Link: | CROMOLYN SODIUM at DailyMed |
Recent Clinical Trials for CROMOLYN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Adli Karadsheh, MD, MS | Phase 3 |
| Texas Tech University Health Sciences Center, El Paso | Phase 3 |
| AZTherapies, Inc. | Phase 2 |
Pharmacology for CROMOLYN SODIUM
| Drug Class | Mast Cell Stabilizer |
| Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for CROMOLYN SODIUM
US Patents and Regulatory Information for CROMOLYN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ailex Pharms Llc | CROMOLYN SODIUM | cromolyn sodium | CONCENTRATE;ORAL | 209264-001 | Oct 16, 2017 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Wockhardt Bio Ag | CROMOLYN SODIUM | cromolyn sodium | SOLUTION;INHALATION | 075346-001 | Oct 25, 1999 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sciegen Pharms Inc | CROMOLYN SODIUM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 074706-001 | Apr 29, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | CROMOLYN SODIUM | cromolyn sodium | CONCENTRATE;ORAL | 202583-001 | Oct 27, 2011 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | CROMOLYN SODIUM | cromolyn sodium | SOLUTION;INHALATION | 075333-001 | Apr 30, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
